FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1508-1511 May 13, 1999 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by McColl, K. PubMed Citation

To the Editor: McColl et al. and Blum et al. (Dec. 24 issue)^1,2 reached opposite conclusions regarding the eradication of Helicobacter pylori infection in patients with nonulcer dyspepsia. In an accompanying editorial, Friedman³ concluded that breakthroughs in the treatment of nonulcer dyspepsia will probably result from basic investigations into visceral sensitivity and brain–gut interactions rather than from further examination of the role of H. pylori infection.

Nonulcer dyspepsia is a heterogeneous condition. It is conceivable that the two studies involved somewhat different groups of patients with different sensitivities to antibiotic treatment. Indeed, one subgroup of patients with nonulcer dyspepsia — . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Pantoflickova, D, Blum, A L (2001). Antagonist: Should we eradicate Helicobacter pylori in non-ulcer dyspepsia?. Gut 48: 758-759 [Full Text]